Does Pfizer's Vaccine Authorization Improve Moderna's Chances?

Pfizer (NYSE: PFE) received U.S. Emergency Use Authorization (EUA) for its COVID-19 vaccine on Dec. 11, 2020. This has raised hopes that Moderna (NASDAQ: MRNA) could soon win EUA for its coronavirus vaccine as well. In this Motley Fool Live video recorded on Dec. 11, healthcare and cannabis bureau chief Corinne Cardina talked with immunotherapy scientist Dr. Leo Nissola about the potential for Pfizer's vaccine authorization to improve Moderna's chances of receiving an EUA for its vaccine.

Continue reading

Source Fool.com